2026-04-17T17:29:56Zhttps://recercat.cat/oai/request

oai:recercat.cat:11351/95652024-12-13T09:19:06Zcom_2072_378070com_2072_378040col_2072_378092

COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP Busca, Alessandro Salmanton-García, Jon Corradini, Paolo Di Blasi, Roberta Marchesi, Francesco Cabirta, Alba Institut Català de la Salut [Busca A] Stem Cell Transplant Center, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Turin, Italy. [Salmanton-García J] Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Faculty of Medicine and University Hospital Cologne, Cologne, Germany. Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University Hospital Cologne, Cologne, Germany. [Corradini P] University of Milan and Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy. [Marchesi F] Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. [Cabirta A] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Di Blasi R] Hôpital Saint Louis, Assistance Publique–Hopitaux de Paris (AP-HP), Paris, France Vall d'Hebron Barcelona Hospital Campus Cèl·lules T Teràpia cel·lular COVID-19 (Malaltia) DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections ANATOMY::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::T-Lymphocytes ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus ANATOMÍA::células::células sanguíneas::leucocitos::leucocitos mononucleares::linfocitos::linfocitos T TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva COVID-19; CAR T cells COVID-19; Cèl·lules CAR T COVID-19; Células CAR T EPICOVIDEHA has received funds from the Optics COMMITTM (COVID-19 Unmet Medical Needs and Associated Research Extension) COVID-19 RFP program by Gilead Sciences (Foster City, CA; project 2020-8223). 2023-05-18T12:20:43Z 2023-05-18T12:20:43Z 2022-04-12 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Busca A, Salmanton-Garcıa J, Corradini P, Marchesi F, Cabirta A, Blasi R Di, et al. COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP. Blood Adv. 2022 Apr 12;6(7):2427–33. 2473-9537 https://hdl.handle.net/11351/9565 10.1182/bloodadvances.2021005616 34749396 http://hdl.handle.net/11351/9565 eng Blood Advances;6(7) https://doi.org/10.1182/bloodadvances.2021005616 Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess application/pdf Elsevier Scientia